The LOBO vascular occlusion system [Image courtesy of Okami Medical]Months after the first use of its LOBO vascular occlusion system on patients, Okami Medical has raised more than $7.2 million.
The company’s low-profile embolic device features a microcatheter to provide smooth peripheral vasculature navigation. When deployed, the occluder self-expands, conforming to a range of targets such as curved vessels.
Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].